|
21 Sep 2025 |
Lupin
|
Consensus Share Price Target
|
2055.60 |
2228.05 |
- |
8.39 |
buy
|
|
|
|
|
11 Nov 2022
|
Lupin
|
Axis Direct
|
2055.60
|
740.00
|
747.00
(175.18%)
|
Target met |
Hold
|
|
|
We expect the company to post stable margins due to improving volumes and a richer product mix. We maintain our HOLD rating on the stock with a revised TP of Rs 740/share.
|
|
11 Nov 2022
|
Lupin
|
ICICI Direct
|
2055.60
|
680.00
|
747.00
(175.18%)
|
Target met |
Sell
|
|
|
|
|
11 Nov 2022
|
Lupin
|
BOB Capital Markets Ltd.
|
2055.60
|
700.00
|
747.00
(175.18%)
|
Target met |
Hold
|
|
|
Q2 revenue grew 11% QoQ (+1% YoY) with recovery in US business and continued momentum in India
|
|
11 Nov 2022
|
Lupin
|
Prabhudas Lilladhar
|
2055.60
|
650.00
|
759.50
(170.65%)
|
Target met |
Hold
|
|
|
|
|
11 Aug 2022
|
Lupin
|
Geojit BNP Paribas
|
2055.60
|
720.00
|
682.85
(201.03%)
|
Target met |
Hold
|
|
|
|
|
05 Aug 2022
|
Lupin
|
Prabhudas Lilladhar
|
2055.60
|
600.00
|
666.65
(208.35%)
|
|
Hold
|
|
|
|
|
05 Aug 2022
|
Lupin
|
ICICI Securities Limited
|
2055.60
|
586.00
|
659.95
(211.48%)
|
|
Sell
|
|
|
Lupin’s Q1FY23 performance was disappointing on profitability front. It reported its worst-ever EBITDA margin of 6.2% (I-Sec: 7.3%) due to restructuring in the US as well as continuous impact of inflation on raw materials and freight. US revenue sharply declined to US$121mn (I-Sec: 180mn) vs US$172/181mn YoY/QoQ on ~US$40-50mn one-time impact of restructuring, inventory write-offs and withdrawal of products.
|
|
05 Aug 2022
|
Lupin
|
ICICI Direct
|
2055.60
|
610.00
|
668.10
(207.68%)
|
|
Sell
|
|
|
|
|
04 Aug 2022
|
Lupin
|
Motilal Oswal
|
2055.60
|
610.00
|
668.10
(207.68%)
|
Target met |
Neutral
|
|
|
|
|
23 May 2022
|
Lupin
|
Axis Direct
|
2055.60
|
670.00
|
618.50
(232.35%)
|
Target met |
Hold
|
|
|
We maintain our HOLD rating on the stock with a revised TP of Rs 670/share.
|